Analysis of relapse and progression after myeloablative allogeneic stem cell transplantation for multiple myeloma

被引：0
|
作者：
Bonifazi, F [1 ]
Bandini, G [1 ]
Giovannini, M [1 ]
Stanzani, M [1 ]
Palandri, F [1 ]
Giannini, B [1 ]
Arpinati, M [1 ]
Falcioni, S [1 ]
Tosi, P [1 ]
Zamagni, E [1 ]
Cangini, D [1 ]
Tacchetti, P [1 ]
Baccarani, M [1 ]
Cavo, M [1 ]
机构：
[1] Inst Haematol Seragnoli, Bologna, Italy
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [41] Allogeneic stem cell transplantation for multiple myeloma: is there a future?
    B Dhakal
    D H Vesole
    P N Hari
    Bone Marrow Transplantation, 2016, 51 : 492 - 500
  • [42] Autologous and allogeneic stem cell transplantation in multiple myeloma
    H Goldschmidt
    G Egerer
    AD Ho
    Bone Marrow Transplantation, 2000, 25 : S25 - S26
  • [43] Salvage therapy with bortezomib in myeloma patients with relapse or progression after stem cell transplantation
    Lakhal, A.
    Boudabous, H.
    Torgeman, L.
    Ladeb, S.
    Barhoumi, W.
    Ben Abdeladhim, A.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S266 - S266
  • [44] Autologous and allogeneic stem cell transplantation in multiple myeloma
    Goldschmidt, H
    Egerer, G
    Ho, AD
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S25 - S26
  • [45] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    Garban, F
    Attal, M
    Rossi, JF
    Payen, C
    Fegueux, N
    Sotto, JJ
    LEUKEMIA, 2001, 15 (04) : 642 - 646
  • [46] Bortezomib therapy for multiple myeloma in relapse after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation (RICT).
    Ducastelle, S
    Revesz, D
    Troncy, J
    Mahmoudi, S
    Thomas, X
    Thiebaut, A
    Nicolini, FE
    Tavernier, E
    Le, QH
    Chelgoum, Y
    Praire, A
    Michallet, M
    BLOOD, 2005, 106 (11) : 436B - 436B
  • [47] Lenalidomide as Salvage Therapy after Allogeneic Stem Cell Transplantation in Multiple Myeloma
    Lehmann, Friederike
    El-Cheilch, Jean, Jr.
    Zabelina, Tatjana
    Ayuk, Francis
    Wolschke, Christine
    Atanackovic, Djordje
    Bacher, Ulrike
    Zander, Axel R.
    Blaisel, Didier
    Mohty, Mohamad
    Kroeger, Nicolaus
    BLOOD, 2008, 112 (11) : 1269 - 1269
  • [48] Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
    C Reynolds
    V Ratanatharathorn
    P Adams
    T Braun
    S Silver
    L Ayash
    E Carson
    A Eisbruch
    LA Dawson
    K McDonagh
    J Ferrara
    J Uberti
    Bone Marrow Transplantation, 2001, 27 : 801 - 807
  • [49] Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
    Reynolds, C
    Ratanatharathorn, V
    Adams, P
    Braun, T
    Silver, S
    Ayash, L
    Carson, E
    Eisbruch, A
    Dawson, LA
    McDonagh, K
    Ferrara, J
    Uberti, J
    BONE MARROW TRANSPLANTATION, 2001, 27 (08) : 801 - 807
  • [50] Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
    L Vincent
    P Ceballos
    C Plassot
    J C Méniane
    P Quittet
    R Navarro
    C Cyteval
    V Szablewski
    Z Y Lu
    T Kanouni
    J Moreaux
    G Cartron
    B Klein
    N Fegueux
    Blood Cancer Journal, 2015, 5 : e341 - e341
12345